rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

532523 BIOCON Group (A)

Biocon Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
449.00   3.10   0.70%
Volume 75,679
Prev close 445.90
Day's H/L (Rs.) 451.55 - 444.40
52wk H/L (Rs.) 553.70 - 402.45
Mkt Cap (Rs. Cr) 8,980.00
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

BIOCON

Biocon Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
447.05   0.75   0.17%
Volume 255,617
Prev close 446.30
Day's H/L (Rs.) 452.00 - 444.00
52wk H/L (Rs.) 553.60 - 402.30
Turnover (Rs. Lacs) 1,143.78
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Biocon Ltd.  (See all 1,029 market voices)   

140 Characters
  Cancel
Ram - 4 day(s) ago [SKB] [SKB] [SKB] [SKB] Wonderful opportunity in market to know the best stock list to invest by SEBI Registered investment adviser visit http://rediff.ly/3mmdi and register
#Biocon-Ltd
Reply   |   Share
Ram - 4 day(s) ago [SKB] [SKB] [SKB] [SKB] Wonderful opportunity in market to know the best stock list to invest by SEBI Registered investment adviser visit http://rediff.ly/3mmdi and register
#Biocon-Ltd
Reply   |   Share

Realtime news for Biocon Ltd. (See all 901 news)

23 May 2015, 11:19
Biocon Q4 net profit increases - 4 day(s) ago
Kiran Mazumdar-Shaw is No 2 on global 'Medicine Maker Power List' 2015 - 12 May 2015
Details dribble out on Biocon's Syngene unit ahead of India IPO - 08 May 2015
Biocon-Mylan Programs Make Progress: PEG-G-CSF and Adalimumab enter Phase 3 clinical trials; Patient recruitment for one Insulin Glargine Phase 3 study completed - 12 May 2015
Biocon subsidiary Syngene to float public issue - 23 Apr 2015

BSE Announcements from Biocon Ltd. (See all)

Biocon's CRO Arm Syngene Seeks Approval for IPO, Files DRHP - 07 May 2015
Biocon - Mylan Programs Make Progress - 07 May 2015

Company details for Biocon Ltd.

Report Card

PE Ratios
24.84
EPS (Rs.)
18.06
Sales (Rs. Cr)
583.38
Face Value (Rs.)
5
Net Profit
Margin (%)
 
14.57
Last Bonus
1:1
Last Dividend(%)
100
Return on
Average Equity
 
13.65

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Biocon Ltd. performance snapshot

If you had invested Rs.  in Biocon Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Biocon Ltd. with other stocks

Ranbaxy Laboratories Ltd.
814.10
GlaxoSmithKline Pharmaceuticals Ltd.
3,203.95
Show more companies
Ranbaxy Laboratories Ltd.
814.10
GlaxoSmithKline Pharmaceuticals Ltd.
3,203.95
Ajanta Pharma Ltd.
1,368.95
Alembic Pharmaceuticals Ltd.
555.65
Apollo Hospitals Enterprise Ltd.
1,298.00
Aurobindo Pharma Ltd.
1,361.20
Cadila Healthcare Ltd.
1,755.55
Cipla Ltd.
674.40
Divi's Laboratories Ltd.
1,840.15
Dr. Reddy's Laboratories Ltd.
3,620.45
Show less companies
Close
Add Biocon Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Biocon Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close